What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
1 Co-sponsor
History
- Substituted by A10219A
- Amended on third reading 7408a
- Advanced to third reading
- 2nd report cal.
- 1st report cal.482
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Relates to insurance coverage for drugs used in cancer treatment
Signed by Governor · Sponsor Rhoda Jacobs
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
Title of bill
An act to amend the insurance law, in relation to insurance coverage for drugs used in cancer treatment
Purpose or general idea of bill
To update the established reference compendia which are used as authoritative sources for use in the determination of off-label drugs and biologicals used in an anticancer chemotherapeutic regimen.
Summary of provisions
Sections 3216, 3221, 4303 and 4900 of the Insurance Law are amended to update the listed standard reference compendia and to allow for future updates to be made without the need for special legislation.
Justification
A uniform policy for the reimbursement of drugs utilized in the treatment of cancer was originally established in New York in 1990. Included in this policy was a listing of standard reference compendia. Due to changes in the pharmaceutical reference industry, two out of the three statutorily-named compendia are no longer published. In 2008 the Centers for Medicare & Medicaid Services (CMS) revised and updated their list of accepted compendia, removing the two compendia which were no longer published (the American Medical Association Drug Evaluations and the United states Pharmacopoeia-Drug Information) and adding three additional compendia (NCCN Drugs and Biologics Compendium, Thomson Micromedex DrugDex, and Elsevier Gold Standard's Clinical Pharmacology).
It is imperative that the laws of New York keep up with the pace of innovation and clinical discovery to allow beneficiaries timely access to the most appropriate treatment options in their battle against cancer. These well established reference compendia help physicians in their ability to access cutting-edge cancer treatments for their patients.
Prior legislative history
None.
Fiscal implications
None.
Effective date
This act shall take effect on the first of January next succeeding the date on which it shall have become a law, and shall apply to all policies and contracts issued, renewed, modified, altered or amended on or after such effective date.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.